Anyone knows how I might get my hands on one? Where do they go after Illumina acquires them for trade in programs? I would prefer to work with a company based in South East Asia if that's possible
-
I have a feeling (no data to back it up) that Illumina re-markets traded-in instruments (at least that appeared to be the case with GA II's) in "cost-conscious" markets. You may want to find a local illumina sales person/FAS and inquire.
You should try to find an instrument in local area since a poster on this forum has reported sky high cost for transportation/re-certification of an instrument from a distant locale.Last edited by GenoMax; 10-01-2014, 03:13 AM.
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment